- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hemostasis in New Zealand
Total 934 results
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.; Ortho Biotech, Inc.TerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
SanofiActive, not recruitingPlasma Cell MyelomaFrance, United States, Australia, Brazil, Canada, Czechia, Greece, Hungary, Italy, Japan, Korea, Republic of, New Zealand, Russian Federation, Spain, Turkey, United Kingdom
-
Memorial Sloan Kettering Cancer CenterCompletedMultiple Myeloma | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
University of RochesterCompletedMultiple Myeloma and Plasma Cell Neoplasm | Drug/Agent Toxicity by Tissue/OrganUnited States
-
Actinium PharmaceuticalsTerminatedRefractory Multiple MyelomaUnited States
-
AbbVieTerminatedMultiple MyelomaUnited States, Australia, France, Germany, Israel, Japan, Spain
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnLymphomaUnited States, Australia, United Kingdom, Canada, France
-
Calithera Biosciences, IncCompletedMultiple Myeloma | Non-Hodgkin's Lymphoma (NHL) | Waldenstrom's Macroglobulinemia (WM) | Other B-cell NHL Subtypes, Including WM | T-cell NHLUnited States
-
GlaxoSmithKlineIqvia Pty LtdCompletedMultiple MyelomaUnited States, Australia, Spain, United Kingdom, Canada
-
University Hospital, EssenRecruitingHereditary Hemorrhagic TelangiectasiaGermany
-
Novo Nordisk A/SCompletedTrauma | Acquired Bleeding DisorderUnited States, Canada
-
AmgenCompletedMultiple MyelomaUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedMultiple MyelomaUnited States, France
-
Novartis PharmaceuticalsCompletedMultiple MyelomaUnited States, Australia
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia BUnited States
-
OncotherapeuticsCelgene CorporationCompletedMultiple MyelomaUnited States
-
Bristol-Myers SquibbAbbVieCompletedSmoldering Multiple MyelomaUnited States
-
Karyopharm Therapeutics IncBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States, Canada
-
CelgeneCompletedMultiple MyelomaUnited States
-
CelgeneCompletedMultiple Myeloma | Renal ImpairmentUnited States, Canada
-
Multiple Myeloma Research ConsortiumEli Lilly and Company; GlaxoSmithKline; AbbVie; Takeda; Genentech, Inc.; Celgene Corporation and other collaboratorsRecruitingRelapsed Refractory Multiple MyelomaUnited States
-
Regeneron PharmaceuticalsRecruitingMultiple MyelomaBelgium, United States, Japan, Korea, Republic of, Germany, Spain, United Kingdom
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...RecruitingRelapsed and/or Refractory Multiple MyelomaUnited States, France, Spain, Germany
-
AbbVieRecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia, Israel, United Kingdom
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedDepression | Pain | Lymphoma | Myelodysplastic Syndromes | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Anxiety DisorderUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Fatigue | Chronic Myeloproliferative Disorders | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous ConditionUnited States
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous ConditionUnited States
-
CelgeneCompletedMultiple MyelomaUnited States, Canada
-
Innate PharmaCompletedSmoldering Multiple MyelomaUnited States
-
GlaxoSmithKlineTerminatedMultiple MyelomaUnited States
-
Johnson & Johnson Private LimitedCompleted
-
Memorial Sloan Kettering Cancer CenterMontefiore Medical Center; St. Jude Children's Research HospitalRecruitingLymphoma | Leukemia | Multiple Myeloma | Colon Cancer | Renal CancerUnited States
-
Jennifer AmengualCompletedLymphoma | Multiple Myeloma | Hodgkin Lymphoma | Lymphoid Malignancies | Non-hodgkin LymphomaUnited States
-
Roswell Park Cancer InstituteCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Yale UniversityCompletedMultiple Myeloma | Influenza | Waldenstrom's Macroglobulinemia | MGUS | Plasma Cell DisordersUnited States
-
Bristol-Myers SquibbCompleted
-
Canadian Cancer Trials GroupAmgen; Canadian Myeloma Research GroupCompleted
-
TakedaCompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States, Canada
-
Novo Nordisk A/STerminatedAcquired Bleeding Disorder | Bleeding During/Following SurgeryUnited States
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.RecruitingRelapsed/Refractory Multiple MyelomaUnited States, France
-
Tragara Pharmaceuticals, Inc.CompletedMultiple Myeloma | AML | Blast Crisis | MDS | ALLUnited States
-
University Hospital, BonnUnknown
-
Genzyme, a Sanofi CompanyCompletedLymphoma, Non-Hodgkin | Multiple MyelomaUnited States
-
Kartos Therapeutics, Inc.CompletedCancer | Glioblastoma | Multiple Myeloma | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States, France, Netherlands
-
University of Michigan Rogel Cancer CenterJanssen Scientific Affairs, LLCActive, not recruiting
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Belgium, China, Israel, Netherlands, Spain, Japan
-
Celgene CorporationCompletedMultiple MyelomaUnited States, Canada
-
Asahi Kasei Pharma America CorporationCompletedSevere Sepsis | CoagulopathyKorea, Republic of, United States, Taiwan, Netherlands, United Kingdom, Australia, Canada, Belgium, Israel, Spain, New Zealand, France, Brazil, India, Argentina, Bulgaria, Croatia, Czechia, Finland, Germany, Hungary, Peru, Russian Federation and more
-
OncotherapeuticsAmgenTerminatedMultiple MyelomaUnited States
-
ImmunoGen, Inc.CompletedMultiple MyelomaUnited States, Argentina